Unraveling immunity to γ-herpesviruses: A new model for understanding the role of immunity in chronic virus infection

Current Opinion in Immunology

Volumn 11, Issue 4, 1999, Pages 371-379

  Virgin IV, Herbert W ^a   Speck, Samuel H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN BCL 2;

B LYMPHOCYTE; HERPES VIRUS INFECTION; HUMAN; MACROPHAGE; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS LATENCY;

EID: 0033178351     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80063-6     Document Type: Article

References (73)

1. Rickinson AB, Kieff E: Epstein-Barr virus. In Virology, Edn 3. Edited by Fields BN, Knipe DM, Howley PM. Philadelphia: Lippincott-Raven; 1996:2397-2446.
2. Kieff E: Epstein-Barr virus and its replication. In Fields' Virology, Edn 3. Edited by Fields B, Knipe D, Howley P. Philadelphia: Lippincott-Raven; 1996:2343-2396.
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
4. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New Engl J Med 1995, 332:1186-1191.
5. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. New Engl J Med 1995, 332:1181-1185.
6. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, D'Agay M-F, Clauvel J-P, Raphael M, Degos L, Signaux F: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280.
7. Jung JU, Trimble JJ, King NW, Biesinger B, Fleckenstein BW, Desrosiers RC: Identification of transforming genes of subgroup A and C strains of herpesvirus saimiri. Proc Natl Acad Sci USA 1991, 88:7051-7055.
8. Murthy SCS, Trimble JJ, Desrosiers RC: Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J Virol 1989, 63:3307-3314.
9. Geck P, Whitaker SA, Medveczky MM, Medveczky PG: Expression of collagen like sequences by a tumor virus, herpesvirus saimiri. J Virol 1990, 64:3509-3515.
10. Medveczky M, Geck P, Sullivan JL, Serbousek D, Djeu JY, Medveczky PG: IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus. Virology 1993, 196:402-412.
11. Simas JP, Efstathiou S: Murine gammaherpesvirus 68: A model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 1998, 6:276-282.
12. Nash AA, Sunil-Chandra NP: Interactions of the murine gammaherpesvirus with the immune system. Curr Opin Immunol 1994, 6:560-563.
13. Nash AA, Usherwood EJ, Stewart JP: Immunological features of murine gammaherpesvirus infection. Semin Virol 1996, 7:125-130.
14. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG: Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 1997, 159:105-117.
15. Doherty PC, Tripp RA, Hamilton-Easton AM, Cardin RD, Woodland DL, Blackman MA: Tuning into immunological dissonance: An experimental model for infectious mononucleosis. Curr Opin Immunol 1997, 9:477-483.
16. Virgin HW, Latreille P, Wamsley P, Hallsworth K, Weck KE, Dal Canto AJ, Speck SH: Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 1997, 71:5894-5904.
17. Efstathiou S, Ho YM, Minson AC: Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol 1990, 71:1355-1364.
18. Efstathiou S, Ho YM, Hall S, Styles CJ, Scott SD, Gompels UA: Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol 1990, 71:1365-1372.
19. Mistrikova J, Blaskovic D: Ecology of the murine alphaherpesvirus and its isolation from lungs of rodents in cell culture. Acta Virol 1985, 29:312-317.
20. Blaskovic D, Stancekova M, Svobodova J, Mistrikova J: Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol 1980, 24:468.
21. Rajcani J, Blaskovic D, Svobodova J, Ciampor F, Huckova D, Stanekova D: Pathogenesis of acute and persistent murine herpesvirus infection in mice. Acta Virol 1985, 29:51-60.
22. Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA: Virological and pathological features of mice infected with murine gammaherpesvirus 68. J Gen Virol 1992, 73:2347-2356.
23. Blaskovic D, Stanekova D, Rajcani J: Experimental pathogenesis of murine herpesvirus in newborn mice. Acta Virol 1984, 28:225-231.
24. Weck KE, Barkon ML, Yoo LI, Speck SH, Virgin HW: Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol 1996, 70:6775-6780.
25. Sunil-Chandra NP, Efstathiou S, Nash AA: Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 1992, 73:3275-3279.
26. Sunil-Chandra NP, Arno J, Fazakerley J, Nash AA: Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Amer J Pathol 1994, 145:818-826.
27. Van Dyk LF, Hess JL, Katz JD, Jacoby M, Speck SH, Virgin HW: The murine gammaherpesvirus 68 v-cyclin is an oncogene that promotes cell cycle progression in primary lymphocytes. J Virol 1999, 73:5110-5112. The authors showed that open reading frame (orf) 72 of γHV68 is a bona fide gene encoding v-Cyclin. Transgenic studies showed that v-Cyclin promotes cell cycle progression in thymocytes and induces lymphoblastic lymphoma in a significant fraction of transgenic mice. This identifies v-Cyclin as the first γHV68 oncogene.
28. Simas JP, Bowden RJ, Paige V, Efstathiou S: Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo. J Gen Virol 1998, 79:149-153.
29. Weck KE, Dal Canto AJ, Gould JD, O'Guin AK, Roth KA, Saffitz JE, Speck SH, Virgin HW: Murine gammaherpesvirus 68 causes large vessel arteritis in mice lacking interferon-gamma responsiveness: A new model for virus induced vascular disease. Nat Med 1997, 3:1346-1353.
30. Dutia BM, Clarke CJ, Allen DJ, Nash AA: Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: A role for CD8 T cells. J Virol 1997, 71:4278-4283.
31. Simas JP, Swann D, Bowden R, Efstathiou S: Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection. J Gen Virol 1999, 80:75-82. The authors perform an extensive transcriptional analysis in vitro and in vivo and find that the M3 genome region of γHV68 is transcribed in the spleen at times when many other probes are negative. This suggests an interesting role for M3 in γHV68 infection, perhaps during the transition to latency.
32. Weck KE, Kim SS, Virgin HW IV, Speck SH: B cells regulate murine gammaherpesvirus 68 latency. J Virol 1999, 73:4561-4661. The authors demonstrate that B cell deficient mice maintain a high frequency of cells that reactivate latent γHV68 at times after infection when normal mice are transitioning from having a high frequency of cells that reactivate the virus to a low frequency. This paper presents the first assay for quantitating the frequency of cells carrying γHV68 genome during latency. The authors use this assay to demonstrate that B cells regulate the efficiency of reactivation from latency rather than the frequency of cells carrying γHV68 genome.
33. Weck KE, Kim SS, Virgin HW IV, Speck SH: Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol 1999, 73:3273-3283. The authors show that macrophages carry latent γHV68 and confirm that B cells carry latent γHV68 genome during latency. This is an important finding as it shows that there are multiple cellular reservoirs of latent γHV68. In addition they show that latent cells can be recruited into sites of inflammation, arguing that a reservoir of cells in the bone marrow may supply latent cells to tissues.
34. Stewart JP, Usherwood EJ, Ross A, Dyson H, Nash T: Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 1998, 187:1941-1951. The authors present data clearly showing lytic infection in the lung of B cell deficient mice at late times after infection. They provide data for a role for B cells in spreading γHV68 and argue that lung epithelial cells are latently infected with γHV68.
35. Sarawar SR, Cardin RD, Brooks JW, Mehrpooya M, Hamilton-Easton A-M, Mo XY, Doherty PC: Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J Virol 1997, 71:3916-3921.
36. Cardin RD, Brooks JW, Sarawar SR, Doherty PC: Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med 1996, 184:863-871.
37. Usherwood EJ, Stewart JP, Robertson K, Allen DJ, Nash AA: Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol 1996, 77:2819-2825.
38. Pollock JL, Virgin HW: Latency, without persistence, of murine cytomegalovirus in spleen and kidney. J Virol 1995, 69:1762-1768.
39. Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ: Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 1997, 71:2980-2987.
40. Mercer JA, Wiley CA, Spector DH: Pathogenesis of murine cytomegalovirus infection: Identification of infected cells in the spleen during acute and latent infections. J Virol 1988, 62:987-997.
41. + T cells in controlling chronic γHV68 infection and possibly latency.
42. Bowden RJ, Simas JP, Davis AJ, Efstathiou S: Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol 1997, 78:1675-1687.
43. Virgin HW, Presti RM, Li X-Y, Liu C, Speck SH: Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol 1999, 73:2321-2332. This is the first paper to clearly demonstrate transcription of the γHV68 genome in latent tissues. Several candidate latency genes are identified. Interestingly, several of these are shared with primate γ-herpesviruses EBV, HVS and KSHV. This argues that γHV68 latency will share important molecular mechanisms of latency with primate γ-herpesviruses.
44. Kedes DH, Lagunoff M, Renne R, Ganem D: Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 1997, 100:2606-2610.
45. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF: The 222- to 234-kilodalton Latent Nuclear Protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 1997, 71:5915-5921.
46. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E: Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997, 385:347-350.
47. van Berkel V, Preiter K, Virgin HW, Speck SH: Identification and initial characterization of a murine gammaherpesvirus 68 gene encoding an abundantly secreted protein. J Virol 1999, 73:4524-4529. The authors show that the M3 open reading frame of γHV68 is a bona fide gene that encodes an abundant secreted protein that is a candidate for manipulating host responses during acute and/or chronic infection.
48. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y: In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995, 86:2708-2714.
49. Decker LL, Shankar P, Khan G, Freeman RB, Dezube BJ, Lieberman J, Thorley-Lawson DA: The Kaposi's sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996, 184:283-288.
50. Zhong W, Wang H, Herndier B, Ganem D: Restricted expression of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi's sarcoma. Proc Natl Acad Sci USA 1996, 93:6641-6646.
51. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y: Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol 1997, 71:314-324.
52. Li JJ, Huang YQ, Cockerell CJ, Friedman-Kien AE: Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Amer J Pathol 1996, 148:1741-1748.
53. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT: Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997, 71:715-719.
54. Sturzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E, Ascherl G, Esser S, Brockmeyer NH, Ekman M et al.: Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 1997, 72:68-71.
55. Pollock JL, Presti RM, Paetzold S, Virgin HW: Latent murine cytomegalovirus infection in macrophages. Virology 1997, 227:168-179.
56. Koffron AJ, Hummel M, Patterson BK, Yan S, Kaufman DB, Fryer JP, Stuart FP, Abecassis MI: Cellular localization of latent murine cytomegalovirus. J Virol 1998, 72:95-103.
57. Usherwood EJ, Ross AJ, Allen DJ, Nash AA: Murine gammaherpesvirus-induced splenomegaly: A critical role for CD4 T cells. J Gen Virol 1996, 77:627-630.
58. Stevenson PG, Doherty PC: Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol 1999, 73:1075-1079. The authors show that in vitro infection of murine B cells results in striking activation of B cells. Given the role of B cells in multiple aspects of γHV68 infection, this is probably an important mechanism for γHV68 pathogenesis.
59. Stevenson PG, Doherty PC: Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol 1998, 72:943-949. The authors document the range and kinetics of host immune responses to γHV68 infection. They demonstrate cytotoxic T lymphocyte activity in a direct assay and the kinetics of both virus-specific and -nonspecific immunoglobulin induction in sera of infected animals.
60. Homann D, Tishon A, Berger DP, Weigle WO, Von Herrath MG, Oldstone MB: Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: Failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. J Virol 1998, 72:9208-9216.
61. Sarawar SR, Cardin RD, Brooks JW, Mehrpooya M, Tripp RA, Doherty PC: Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol 1996, 70:3264-3268.
62. Kulkarni AB, Holmes KL, Fredrickson TN, Hartley JW, Morse HC: Characteristics of a murine gammaherpesvirus infection immunocompromised mice. In Vivo 1997, 11:281-291.
63. + T cell action against γHV68.
64. Ehtisham S, Sunil-Chandra NP, Nash AA: Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol 1993, 67:5247-5252.
65. + T cells are persistently activated over very long periods after acute γHV68 infection.
66. + T cells.
67. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW: Interferon-gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 1998, 188:577-588.
68. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH: Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med 1989, 169:1199-1212.
69. Jonjic S, Pavic I, Lucin P, Rukavina D, Koszinowski UH: Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol 1990, 64:5457-5464.
70. Lucin P, Pavic I, Polic B, Jonjic S, Koszinowski UH: Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 1992, 66:1977-1984.
71. Tripp RA, Hamilton-Easton AM, Cardin RD, Nguyen P, Behm FG, Woodland DL, Doherty PC, Blackman MA: Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: Role for a viral superantigen? J Exp Med 1997, 185:1641-1650.
72. Stevenson PG, Belz GT, Altman JD, Doherty PC: Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol 1999, 29:1059-1067.
73. Usherwood EJ, Brooks JW, Sarawar SR, Cardin RD, Young WD, Allen DJ, Doherty PC, Nash AA: Immunological control of murine gammaherpesvirus infection is independent of perform. J Gen Virol 1997, 78:2025-2030.